Jacob Glanville Bio: The Centivax Founder’s Age, Height, Net Worth, Netflix Fame, Career & Latest Medical Breakthroughs (2026)

Jacob Glanville is a world-renowned American computational immuno-engineer, entrepreneur, and scientist best known as the founder of Centivax and for his starring role in the Netflix docuseries Pandemic: How to Prevent an Outbreak. As a leading figure in the global effort to develop a universal flu vaccine and advanced antibody therapies, Glanville has bridged the gap between high-level genetic engineering and mainstream public health awareness. In this Jacob Glanville bio, we explore his journey from a childhood in Mexico to becoming one of the most influential figures in modern biotechnology by 2026.

Quick Facts

Early Life & Education

Childhood and Cross-Cultural Roots

Jacob Glanville was born in 1982 in a small rural town in Baja California, Mexico. His parents were American expatriates; his mother was a nurse and his father was a builder. Growing up in a resource-limited environment in Mexico provided Glanville with a unique perspective on global health disparities from a young age. Living in a community where medical care was not always guaranteed sparked an early interest in how biology and medicine could be used to protect large populations.

In his youth, Glanville was known for being a voracious reader with an insatiable curiosity about the natural world. He often credits his parents for fostering an environment of “intellectual fearlessness,” encouraging him to ask difficult questions and seek out complex answers.

School Years

After his family moved back to the United States, Glanville attended high school where he excelled in the sciences. Unlike many students who focused purely on biology, Glanville showed a distinct aptitude for the intersection of mathematics and nature. He was fascinated by the patterns found in biological systems, a trait that would later define his career in “computational” immunology—using computers to map the human immune system.

University & Training

Glanville attended the University of California, Berkeley, for his undergraduate studies. He earned his Bachelor of Arts in Integrative Biology, a field that allowed him to look at biological systems as a whole rather than in isolation.

Following his undergraduate success, he pursued his PhD at Stanford University. At Stanford, he worked in the lab of Mark Davis, one of the world’s foremost immunologists. His doctoral research focused on high-throughput DNA sequencing of the immune system. It was during this time that he began developing the algorithms that could “read” the language of antibodies, effectively predicting how the human body reacts to different pathogens.

Career Journey

The Pfizer Era and Early Innovation

Jacob Glanville’s professional career began at the pharmaceutical giant Pfizer. During his tenure there, he worked as a Principal Scientist. His role was centered on the development of “computational antibody engineering” platforms. At Pfizer, Glanville realized that the traditional method of discovering new drugs was too slow and often relied on trial and error. He began conceptualizing a way to use massive datasets to engineer medicines with mathematical precision.

Founding Distributed Bio

In 2012, Glanville left the corporate world to co-found Distributed Bio. This boutique San Francisco-based biotech firm became an industry powerhouse by licensing its advanced software and antibody libraries to almost every major pharmaceutical company in the world.

The success of Distributed Bio was built on the “SuperHuman” library—a massive, synthetically engineered collection of billions of human antibodies. This library allowed researchers to find potential cures for diseases in weeks rather than years. By 2020, Distributed Bio was the engine behind dozens of drug discovery programs globally.

Netflix Fame: “Pandemic: How to Prevent an Outbreak”

In early 2020, just as the COVID-19 pandemic was beginning to spread, Netflix released the docuseries Pandemic: How to Prevent an Outbreak. Jacob Glanville was one of the central figures in the series. The show followed his team’s grueling efforts to create a “universal flu vaccine”—a shot that would provide lifelong protection against all strains of the influenza virus.

His appearance on the show made him a household name. Viewers were drawn to his articulate explanations of complex science and his palpable passion for preventing global catastrophes. This “Netflix fame” catapulted Glanville into the public eye, making him a sought-after expert for news outlets including CNN, MSBNC, and the New York Times during the peak of the 2020-2022 health crisis.

The Launch of Centivax

In late 2020, Distributed Bio’s technology platform was acquired by Charles River Laboratories in a multi-million dollar deal. However, Glanville retained the therapeutics arm of the company, spinning it off into a new entity: Centivax.

As the CEO and President of Centivax, Glanville pivoted his focus toward creating “breakthrough” medicines. Centivax was designed as a therapeutics company focused on the most difficult-to-solve problems in medicine, including:

• Universal Influenza Vaccines
• Broad-spectrum COVID-19 antibody treatments
• Anti-venom for snake bites
• Therapies for antimicrobial-resistant (AMR) bacteria

Recent Activity and 2026 Breakthroughs

As of 2026, Jacob Glanville has reached several major milestones. Centivax-101, the company’s lead universal flu vaccine candidate, has successfully moved through Phase II human clinical trials with unprecedented results. The data suggests that the vaccine provides robust protection against “drifted” strains of the flu that traditional annual shots miss.

Furthermore, Glanville has been at the forefront of integrating Generative AI into immunology. In 2025, his team released a landmark paper on “Autonomous Antibody Synthesis,” where AI models were used to design entirely new proteins to neutralize emerging viral threats before they could even jump from animals to humans.

Career Stats & Milestones

Net Worth & Earnings

Jacob Glanville’s net worth is estimated to be between $75 million and $100 million as of 2026. His wealth is derived from several sophisticated income streams:

1. The Charles River Acquisition: In 2020, Charles River Laboratories acquired the assets of Distributed Bio. While the exact personal payout was not fully disclosed, the deal was valued in the high eight figures, providing Glanville with significant capital.
2. Equity in Centivax: As the majority owner and founder of Centivax, his net worth is heavily tied to the company’s valuation. Following successful Phase II trials in 2025, Centivax’s private valuation soared, attracting over $200 million in Series B and C funding rounds.
3. Intellectual Property & Licensing: Glanville holds numerous patents in the field of computational immunology. Licensing these patents to other biotech firms generates passive, high-margin revenue.
4. Consulting & Speaking: As a public intellectual and recognized “Netflix doctor,” Glanville earns significant fees for keynote speaking engagements at global health summits and tech conferences.

Real Estate and Investments: Glanville maintains a residence in the San Francisco Bay Area, an expensive hub for biotech. He is also known to invest in “frontier tech” startups, particularly those focusing on environmental sustainability and AI-driven healthcare.

Personal Life

Family Background

Despite his public profile, Glanville keeps his immediate family life relatively private. He is known to be very close to his parents, often citing their influence in his public interviews. He has mentioned in passing that his multicultural upbringing in Mexico remains a core part of his identity.

Marriage & Children

Jacob Glanville is married and has two children. He has often spoken about how being a father changed his perspective on his work. During the 2020 pandemic, he frequently noted that his drive to create a universal vaccine was fueled by a desire to ensure his children—and all children—never had to live through a world-shuttering lockdown again.

Hobbies, Interests & Lifestyle

When he is not in the lab or running a company, Glanville is an enthusiast of high-tech gadgetry and science fiction. He is a supporter of “Longtermism,” the philosophical view that we should be doing more to protect the future of humanity from existential risks. He is also an avid traveler, often returning to Mexico to visit his childhood roots and support local health initiatives.

Awards & Achievements

• Global Health Innovator Award | 2025 | International Bio-Tech Association
• Top 40 Under 40 in Life Sciences | 2021 | Business Insider
• Fast Company Most Productive People | 2020 | Fast Company
• Pioneer in Computational Immunology | 2019 | Stanford University
• Gates Foundation Grand Challenge Winner | 2018 | Bill & Melinda Gates Foundation

Physical Statistics

Jacob Glanville maintains a lean, athletic build, which he attributes to a disciplined routine and the high-energy nature of his work.

• Height: 6 feet 1 inch (185 cm)
• Weight: 185 lbs (84 kg)
• Eye Color: Blue
• Hair Color: Brown
• Notable Attributes: Known for his expressive hand gestures during scientific explanations and a professional yet approachable style of dress (often seen in blazers or high-tech outdoor gear).

Quotes

“The goal of science shouldn’t just be to understand the world, but to engineer it so that it’s no longer a threat to the people we love.” — Web Summit Keynote, 2023

“We are the first generation in human history that has the tools to read the code of life and rewrite the parts that cause us pain.” — Netflix’s Pandemic, 2020

“Computers are the microscopes of the 21st century. They allow us to see patterns in our immune systems that the human eye simply can’t process.” — Nature Biotechnology Interview, 2025

Favorites

• Favorite Book: The Beginning of Infinity by David Deutsch
• Favorite Travel Destination: Baja California, Mexico
• Favorite Technology: CRISPR and Large Language Models (LLMs)
• Favorite Cuisine: Authentic Mexican street food
• Favorite Hobby: Studying the philosophy of science

Interesting Facts

• Multilingual: Jacob is fluent in both English and Spanish, which has helped him collaborate with international health organizations in Latin America.
• Self-Taught Coder: While his PhD is in Immunology, much of his early coding skills used to build Distributed Bio’s software were self-taught.
• Snake Venom Expert: One of Centivax’s most unique projects is creating a “universal anti-venom” using the same tech they use for flu vaccines.
• Musician: In his younger years, Glanville was involved in music and has a deep appreciation for the mathematics found in musical composition.
• Comic Book Fan: He has compared the engineering of antibodies to “designing a superhero’s suit” for the human body.
• Public Speaker: He has given multiple TEDx talks and is considered one of the best “science communicators” of the modern era.
• Philanthropist: He regularly donates technology and expertise to labs in developing countries to help them build their own localized medicine capabilities.
• Bio-Security Advocate: He has met with several world leaders to discuss the risks of laboratory-leaked pathogens and natural biothreats.

Did You Know?

• Did you know Jacob Glanville grew up in a house built by his father in rural Mexico without traditional urban utilities?
• Did you know he once worked at Pfizer but left because he felt the corporate structure moved too slowly for radical innovation?
• Did you know Centivax was born from the idea that we can create “one shot for life” to end the flu forever?
• Did you know he was filming the Netflix show Pandemic before anyone knew a real global pandemic was about to strike?

Social Media

• Instagram → @jacobglanville
• X (Twitter) → @jacobglanville
• LinkedIn → Jacob Glanville PhD
• Official Website → Centivax.com

Frequently Asked Questions

Q1: How old is Jacob Glanville in 2026?
As of 2026, Jacob Glanville is approximately 44 years old. He was born in 1982.

Q2: What is Jacob Glanville’s most famous work?
He is most famous for his work on a universal influenza vaccine and his appearance in the 2020 Netflix documentary Pandemic: How to Prevent an Outbreak.

Q3: Is Jacob Glanville still the CEO of Centivax?
Yes, as of 2026, he remains the CEO and President of Centivax, overseeing clinical trials for multiple therapeutic programs.

Q4: Did Jacob Glanville create a cure for COVID-19?
While he didn’t create a “cure” in the traditional sense, his company Centivax developed highly potent neutralizing antibodies that were used in the development of treatments for various COVID-19 variants.

Q5: What is Jacob Glanville’s net worth?
His estimated net worth in 2026 is between $75 million and $100 million, largely due to the success of Distributed Bio and his ownership in Centivax.

CONCLUSION

Jacob Glanville has transformed from a passionate scientist into a global leader in biotechnology and a symbol of hope for a future free from infectious diseases. His work with Centivax and his ability to communicate complex science to the masses have solidified his legacy as a pioneer of computational immunology. As he continues to push the boundaries of AI and medicine in 2026, the world watches closely to see if his vision of a universal flu vaccine will finally become a reality.

If you found this biography insightful, feel free to share it with others interested in the future of medicine and the people shaping it.

Sources:

• Stanford University Department of Immunology Archives
• Centivax Corporate Press Releases (2021–2026)
• Netflix Official Series: Pandemic: How to Prevent an Outbreak (2020)
• Nature Biotechnology Publication Records
• Forbes Science & Technology Features